Biotech Analyst Jay Silverman, Industry Guru Jim McCamant Featured On Today's Informed Investors Radio Forum.SACRAMENTO, Calif.--(BUSINESS WIRE)--July 22, 1999-- Biotech analyst Jay Silverman of BancBoston Robertson Stephens joins Jim McCamant, long-time editor of the Medical Technology Stock Letter, as featured guests on today's Informed Investors Radio Forum from 2-3 p.m. Eastern time (11 a.m.-noon PDT). The show is carried live on the Internet over broadcast.com via the Realplayer on your PC. In addition to the special guests, Tim Fredel, publisher of BioSpace.com (www.biospace.com), will give a quick overview of recent developments in the sector. To tune in, visit www.informedinvestors.com and click the link. Internet listeners can email questions to cohost co·host or co-host n. A joint host, as of a social event. tr.v. co·host·ed, co·host·ing, co·hosts To serve as a joint host of: Tim Quast at tim@informedinvestors.com. Silverman, a managing director and senior research analyst, joined Robby Stephens (www.rsco.com) in 1997 as part of the life sciences group. He covers both first-generation biotechnology companies and other emerging biopharmaceutical firms. Some of the companies he follows are: Abgenix (Nasdaq:ABGX); Alkermes (Nasdaq:ALKS ALKS Alkermes, Inc. (stock symbol) ); Amgen (Nasdaq:AMGN); Biogen (Nasdaq:BGEN BGen abbr. brigadier general ); Centocor (Nasdaq:CNTO CNTO China National Tourist Office ); Cephalon (Nasdaq:CEPH CEPH Council on Education for Public Health CEPH Centre d'Etude du Polymorphisme Humain ); and MedImmune (Nasdaq:MEDI MEDI Marine Environmental Data Information Referral System ). Silverman previously spent five years as a vice president and senior analyst for biotechnology and medical technology at Schroder Wertheim & Co. In 1999, he was chosen as a Wall Street Journal All-Star Analyst and was ranked No. 3 among the 24 biotech analysts honored. McCamant has been following biotechnology companies since Genentech's initial public offering in 1980 and has edited the Medical Technology Stock Letter (www.bioinvest.com) since its inception in 1983. Each issue of MTSL MTSL Monitoring and Technical Support Laboratory MTSL Message Transfer SubLayer contains an analysis of present market conditions, a featured article related to investing in biotechnology, updates on developments concerning recommended companies, and a page tracking the performance of current recommendations and the MTSL's model and aggressive portfolios. McCamant follows a wide variety of stocks in the sector, including: Amylin Pharmaceuticals (Nasdaq:AMLN), Chiron (Nasdaq:CHIR), ICOS Corp. (Nasdaq:ICOS), Immunex (Nasdaq:IMNX), Maxim Pharmaceuticals (Amex:MMP), NeXstar Pharmaceuticals (Nasdaq:NXTR) and XOMA Corp. (Nasdaq:XOMA). In addition to its weekly radio show, Informed Investors Forum is the leading producer of industry-specific investment conferences for the retail investment community. The next two are the Seventh San Francisco Bay Area “Bay Area” redirects here. For other uses, see Bay Area (disambiguation). The San Francisco Bay Area, colloquially known as the Bay Area or The Bay Biotechnology Stocks Forum on Saturday, July 24 in Berkeley, and the Fifth San Diego BioMedical Stocks Forum on Saturday, July 31. Details are at www.informedinvestors.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion